AIM: To improve treatment results of @entity1 with @entity9527 using hypercapnic @entity519 as a part of an integrated therapy. MATERIALS AND METHODS: The study involved 37 @entity1 aged 20 to 50 years diagnosed with @entity9527 . The subjects were randomly divided into 2 groups. The control group consisted of 17 (46%) @entity1 who received only the basic therapy. The study group comprised 20 (54%) @entity1 , who were treated with the basic therapy combined with a course of 10 treatment sessions of hypercapnic @entity519 using a respiratory device. Two study visits were organized before and after treatment, including medical history, physical examination, filling out questionnaires, DRE and TRUS of the prostate, uroflowmetry and laser flowmetry. RESULTS: In the both groups, the treatment resulted in reduction or relief of @entity158 and @entity3833 that is a natural effect of the standard therapy. However, the study group showed significantly greater improvement. The findings of DRE and TRUS of the prostate in the study and control group did not differ significantly; the size of hypoechoic areas in the prostate decreased in the both groups. Laser flowmetry showed improvement in microcirculatory disturbances of the prostate, which were observed before treatment. CONCLUSION: Basic therapy has a clinical effect, but it is limited regarding hemodynamics and microcirculation of the prostate. These indices are lower than in the study group. Thus, the study findings show a high clinical efficacy of hypercapnic @entity519 as an add-on therapy in treating @entity1 with @entity9527 . There was a significant decrease in clinical manifestations of the disease which was caused by improving microcirculation. This resulted from improved blood circulation, increased blood perfusion and blood volume in the arterioles, increased blood inflow in the microcirculatory system, reduced tissue @entity519 and @entity63 , improved blood flow regulation. The findings of the present study give us ground to recommend training using breathing simulator "Karbonik" in the combination therapy of @entity1 with @entity9527 , which significantly increases the treatment effectiveness.

[Effect of hypercapnic XXXX on chronic abacterial prostatitis].

@entity1 :: ('9606', 'Species') :: ['patients', 'men'] @entity63 :: ('MESH:D007511', 'Disease') :: ['ischemia'] @entity519 :: ('MESH:D000860', 'Disease') :: ['hypoxia'] @entity3833 :: ('MESH:D053159', 'Disease') :: ['dysuria'] @entity158 :: ('MESH:D010146', 'Disease') :: ['pain'] @entity9527 :: ('OMIM:115650', 'Disease') :: ['CAP']
@entity519 :: (MESH:D000860,Disease) :: ['hypoxia']
